Real world studies in complex treatments

This leading global Biopharma company needed to generate real-world evidence on its oncology drug, to meet the needs of regulatory approval as well as establish health economics outcomes.

Baseline Plus was deployed to support a health economics study in 163 sites and 1583 patients across 9 countries. The study supported a complex patient lifecycle. The features and functionalities built into Baseline Plus enabled the study to achieve high quality data without high data management costs.